Freedom Wealth Alliance, LLC Chembio Diagnostics, Inc. Transaction History

Freedom Wealth Alliance, LLC

  • $60.8 Billion
  • Q3 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.2 - $0.33 $1,966 - $3,244
9,831 New
9,831 $2.16 Million

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Freedom Wealth Alliance, LLC Portfolio

Follow Freedom Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Wealth Alliance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email